Investigational drugs for fracture healing: preclinical & clinical data

References

• Van Staa TP, Dennison EM, Leufkens HGM, et al. Epidemiology of fractures in England and Wales. Bone. 2001;29:517–522.
   PubMed Web of Science ®Google Scholar
• Calori GM, Albisetti W, Agus A, et al. Risk factors contributing to fracture non-unions. Injury. 2007;38:S11–8.
   PubMed Web of Science ®Google Scholar
• Marsell R, Einhorn TA. The biology of fracture healing. Injury. 2011;42:551–555.
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Oka H, Jingushi S, et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial. J Bone Miner Res. 2010;25:2735–43.
   PubMed Web of Science ®Google Scholar
• Garrison KR, Shemilt I, Donell S, et al. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst Rev. 2010;16(6):CD006950.
   Google Scholar
• Ishida K, Matsumoto T, Sasaki K, et al. Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng Part A. 2010;16:3271–3284.
   PubMed Web of Science ®Google Scholar
• Garcia P, Schwenzer S, Slotta JE, et al. Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation – role of a local renin-angiotensin system. Br J Pharmacol. 2010;159:1672–1680.
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang J-X, Feng Y-F, et al. Systemic treatment with telmisartan improves femur fracture healing in mice. PLoS ONE. 2014;9:e92085.
   PubMed Web of Science ®Google Scholar
• Histing T, Marciniak K, Scheuer C, et al. Sildenafil accelerates fracture healing in mice. J Orthop Res. 2011;29:867–873.
   PubMed Web of Science ®Google Scholar
• Brandi ML. Healing of the bone with anti-fracture drugs. Expert Opin Pharmacother. 2013;14:1441–1447.
   PubMed Web of Science ®Google Scholar
• Rogers MJ, Crockett JC, Coxon FP, et al. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. 2011;49:34–41.
   PubMed Web of Science ®Google Scholar
• Goldhahn J, Féron JM, Kanis J, et al. Implications for fracture healing of current and new osteoporosis treatments: an ESCEO consensus paper. Calcif Tissue Int. 2012;90:343–353.
   PubMed Web of Science ®Google Scholar
• Li YF, Li XD, Bao CY, et al. Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Osteoporos Int. 2013;24:1063–1071.
   PubMed Web of Science ®Google Scholar
• Li YF, Zhou CC, Li JH, et al. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. Osteoporos Int. 2012;23:1463–1474.
   PubMed Web of Science ®Google Scholar
• Colón-Emeric C, Nordsletten L, Olson S, et al. Association between timing of zoledronic acid infusion and hip fracture healing. Osteoporos Int. 2011;22:2329–36.
   PubMed Web of Science ®Google Scholar
• Toker H, Ozdemir H, Ozer H, et al. Alendronate enhances osseous healing in a rat calvarial defect model. Arch Oral Biol. 2012;57:1545–1550.
   PubMed Web of Science ®Google Scholar
• Mathijssen NM, Hannink G, Pilot P, et al. Impregnation of bone chips with alendronate and cefazolin, combined with demineralized bone matrix: a bone chamber study in goats. BMC Musculoskelet Disord. 2012;13:44.
   PubMed Web of Science ®Google Scholar
• Stuermer EK, Sehmisch S, Rack T, et al. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat. Langenbecks Arch Surg. 2010;395:163–172.
   PubMed Web of Science ®Google Scholar
• Spiro AS, Khadem S, Jeschke A, et al. The SERM raloxifene improves diaphyseal fracture healing in mice. J Bone Miner Metab. 2013;31:629–636.
   PubMed Web of Science ®Google Scholar
• Li YF, Luo E, Feng G, et al. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats. Osteoporos Int. 2010;21:1889–1897.
   PubMed Web of Science ®Google Scholar
• Zacchetti G, Dayer R, Rizzoli R, et al. Systemic treatment with strontium ranelate accelerates the filling of a bone defect and improves the material level properties of the healing bone. Biomed Res Int. 2014;2014:549785.
   PubMed Web of Science ®Google Scholar
• Brüel A, Olsen J, Birkedal H, et al. Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures. Calcif Tissue Int. 2011;88:142–152.
   PubMed Web of Science ®Google Scholar
• Scaglione M, Fabbri L, Casella F, et al. Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures. Osteoporos Int. 2016;27(1):211–218.
   PubMed Web of Science ®Google Scholar
• Mognetti B, Marino S, Barberis A, et al. Experimental stimulation of bone healing with teriparatide: histomorphometric and microhardness analysis in a mouse model of closed fracture. Calcif Tissue Int. 2011;89:163–171.
   PubMed Web of Science ®Google Scholar
• Komrakova M, Stuermer EK, Werner C, et al. Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone. 2010;47:480–492.
   PubMed Web of Science ®Google Scholar
• Ellegaard M, Kringelbach T, Syberg S, et al. The effect of PTH(1-34) on fracture healing during different loading conditions. J Bone Miner Res. 2013;28:2145–2155.
   PubMed Web of Science ®Google Scholar
• Tägil M, McDonald MM, Morse A, et al. Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures. Bone. 2010;46:852–859.
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Genant HK, Johansson T, et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res. 2010;25:404–4.
   PubMed Web of Science ®Google Scholar
• Aspenberg P, Johansson T. Teriparatide improves early callus formation in distal radial fractures. Acta Orthop. 2010;81:234–236.
   PubMed Web of Science ®Google Scholar
• Peichl P, Holzer LA, Maier R, et al. Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am. 2011;93:1583–1587.
   PubMed Web of Science ®Google Scholar
• Feng G, Chang-Qing Z, Yi-Min C, et al. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats. Int Immunopharmacol. 2015;24:7–13.
   PubMed Web of Science ®Google Scholar
• Suen PK, He Y-X, Chow DHK, et al. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats. J Orthop Res. 2014;32:997–1005.
   PubMed Web of Science ®Google Scholar
• Padhi D, Jang G, Stouch B, et al. Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody. J Bone Miner Res. 2011;26:19–26.
   PubMed Web of Science ®Google Scholar
• Gamie Z, Korres N, Leonidou A, et al. Sclerostin monoclonal antibodies on bone metabolism and fracture healing. Expert Opin Investig Drugs. 2012;21:1523–1534.
   PubMed Web of Science ®Google Scholar
• Jin H, Wang B, Li J, et al. Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling. Bone. 2015;71:63–75.
   PubMed Web of Science ®Google Scholar
• Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004;22:233–241.
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am. 2002;84-A:1032–1044.
   PubMed Web of Science ®Google Scholar
• Bragdon B, Moseychuk O, Saldanha S, et al. Bone morphogenetic proteins: a critical review. Cell Signal. 2011;23:609–620.
   PubMed Web of Science ®Google Scholar
• Canalis E, Economides AN, Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev. 2003;24:218–235.
   PubMed Web of Science ®Google Scholar
• Ryoo H-M, Lee M-H, Kim Y-J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene. 2006;366:51–57.
   PubMed Web of Science ®Google Scholar
• Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A:2123–34.
   PubMed Web of Science ®Google Scholar
• Jones AL, Bucholz RW, Bosse MJ, et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431–41.
   PubMed Web of Science ®Google Scholar
• Friedlaender GE, Perry CR, Cole JD, et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am. 2001;83-A(Suppl 1):S151–8.
   PubMed Web of Science ®Google Scholar
• Axelrad TW, Steen B, Lowenberg DW, et al. Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J Bone Joint Surg Br. 2008;90:1617–1622.
   PubMed Web of Science ®Google Scholar
• Carofino BC, Lieberman JR. Gene therapy applications for fracture-healing. J Bone Joint Surg Am. 2008;90(Suppl 1):99–110.
   PubMed Web of Science ®Google Scholar
• Lieberman JR, Daluiski A, Stevenson S, et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am. 1999;81:905–917.
   PubMed Web of Science ®Google Scholar
• Grgurevic L, Macek B, Mercep M, et al. Bone morphogenetic protein (BMP)1-3 enhances bone repair. Biochem Biophys Res Commun. 2011;408:25–31.
   PubMed Web of Science ®Google Scholar
• Lee SS, Huang BJ, Kaltz SR, et al. Bone regeneration with low dose BMP-2 amplified by biomimetic supramolecular nanofibers within collagen scaffolds. Biomaterials. 2013;34:452–459.
   PubMed Web of Science ®Google Scholar
• Kim RY, Oh JH, Lee BS, et al. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterials. 2014;35:1869–1881.
   PubMed Web of Science ®Google Scholar
• Li L, Zhou G, Wang Y, et al. Controlled dual delivery of BMP-2 and dexamethasone by nanoparticle-embedded electrospun nanofibers for the efficient repair of critical-sized rat calvarial defect. Biomaterials. 2015;37:218–229.
   PubMed Web of Science ®Google Scholar
• Hou J, Wang J, Cao L, et al. Segmental bone regeneration using rhBMP-2-loaded collagen/chitosan microspheres composite scaffold in a rabbit model. Biomed Mater. 2012;7:035002.
   PubMed Web of Science ®Google Scholar
• Shekaran A, García JR, Clark AY, et al. Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle. Biomaterials. 2014;35:5453–5461.
   PubMed Web of Science ®Google Scholar
• Wang H, Zou Q, Boerman OC, et al. Combined delivery of BMP-2 and bFGF from nanostructured colloidal gelatin gels and its effect on bone regeneration in vivo. J Control Rel. 2013;166:172–181.
   PubMed Web of Science ®Google Scholar
• Chatzinikolaidou M, Lichtinger TK, Müller RT, et al. Peri-implant reactivity and osteoinductive potential of immobilized rhBMP-2 on titanium carriers. Acta Biomaterialia. 2010;6:4405–4421.
   PubMed Web of Science ®Google Scholar
• Sebald H-J, Klenke FM, Siegrist M, et al. Inhibition of endogenous antagonists with an engineered BMP-2 variant increases BMP-2 efficacy in rat femoral defect healing. Acta Biomaterialia. 2012;8:3816–3820.
   PubMed Web of Science ®Google Scholar
• Doi Y, Miyazaki M, Yoshiiwa T, et al. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model. Bone. 2011;49:777–782.
   PubMed Web of Science ®Google Scholar
• Liu T, Wu G, Wismeijer D, et al. Deproteinized bovine bone functionalized with the slow delivery of BMP-2 for the repair of critical-sized bone defects in sheep. Bone. 2013;56:110–118.
   PubMed Web of Science ®Google Scholar
• Mathavan N, Bosemark P, Isaksson H, et al. Investigating the synergistic efficacy of BMP-7 and zoledronate on bone allografts using an open rat osteotomy model. Bone. 2013;56:440–448.
   PubMed Web of Science ®Google Scholar
• Seeherman HJ, Li XJ, Smith E, et al. rhBMP-2/Calcium phosphate matrix induces bone formation while limiting transient bone resorption in a nonhuman primate core defect model. J Bone Joint Surg Am. 2012;94:1765–1776.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Priddy LB, Esancy C, et al. Hydrogel-based Delivery of rhBMP-2 improves healing of large bone defects compared with autograft. Clin Orthop Relat Res. 2015;473:2885–2897.
   PubMed Web of Science ®Google Scholar
• Li M, Liu X, Liu X, et al. Calcium phosphate cement with BMP-2-loaded gelatin microspheres enhances bone healing in osteoporosis: A pilot study. Clin Orthop Relat Res. 2010;468:1978–1985.
   PubMed Web of Science ®Google Scholar
• Liao JC, Tzeng ST, Keorochana G, et al. Enhancement of recombinant human BMP‐7 bone formation with bmp binding peptide in a rodent femoral defect model. J Orthop Res. 2011;29:753–759.
   PubMed Web of Science ®Google Scholar
• Mariner PD, Wudel JM, Miller DE, et al. Synthetic hydrogel scaffold is an effective vehicle for delivery of INFUSE (rhBMP2) to critical‐sized calvaria bone defects in rats. J Orthop Res. 2013;31:401–406.
   PubMed Web of Science ®Google Scholar
• Faßbender M, Minkwitz S, Strobel C, et al. Stimulation of bone healing by sustained bone morphogenetic protein 2 (BMP-2) delivery. Int J Mol Sci. 2014;15:8539–8552. doi:10.3390/ijms15058539.
   PubMed Web of Science ®Google Scholar
• Li X, Yi W, Jin A, et al. Effects of sequentially released BMP-2 and BMP-7 from PELA microcapsule-based scaffolds on the bone regeneration. Am J Transl Res. 2015;7:1417.
   PubMed Web of Science ®Google Scholar
• Schützenberger S, Schultz A, Hausner T, et al. The optimal carrier for BMP-2: a comparison of collagen versus fibrin matrix. Arch Orthop Trauma Surg. 2012;132:1363–1370.
   PubMed Web of Science ®Google Scholar
• Abbah S-A, Lam WMR, Hu T, et al. Sequestration of rhBMP-2 into self-assembled polyelectrolyte complexes promotes anatomic localization of new bone in a porcine model of spinal reconstructive surgery. Tissue Eng Part A. 2014;20:1679–1688.
   PubMed Web of Science ®Google Scholar
• Behr B, Sorkin M, Lehnhardt M, et al. A comparative analysis of the osteogenic effects of BMP-2, FGF-2, and VEGFA in a calvarial defect model. Tissue Eng Part A. 2012;18:1079–1086.
   PubMed Web of Science ®Google Scholar
• Yoon BH, Esquivies L, Ahn C, et al. An activin A/BMP2 chimera, AB204, displays bone‐healing properties superior to those of BMP2. J Bone Miner Res. 2014;29:1950–1959.
   PubMed Web of Science ®Google Scholar
• Curtin CM, Tierney EG, McSorley K, et al. Combinatorial gene therapy accelerates bone regeneration: non‐viral dual delivery of VEGF and BMP2 in a collagen‐nanohydroxyapatite scaffold. Adv Healthc Mater. 2015;4:223–227.
   PubMed Web of Science ®Google Scholar
• Seeherman HJ, Li XJ, Bouxsein ML, et al. rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model. J Bone Joint Surg Am. 2010;92:411.
   PubMed Web of Science ®Google Scholar
• Opie LH. Present status of statin therapy. Trends Cardiovasc Med. 2015;25:216–225.
   PubMed Web of Science ®Google Scholar
• Ruiz Gaspa S, Nogues X, Enjuanes A, et al. Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG‐63 cultures. J Cell Biochem. 2007;101:1430–1438.
   PubMed Web of Science ®Google Scholar
• Maeda T, Matsunuma A, Kurahashi I, et al. Induction of osteoblast differentiation indices by statins in MC3T3‐E1 cells. J Cell Biochem. 2004;92:458–471.
   PubMed Web of Science ®Google Scholar
• Tai IC, Wang YH, Chen CH, et al. Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells’ osteogenic differentiation. Int J Nanomed. 2015; 10:5881–5894.
   PubMed Web of Science ®Google Scholar
• Yueyi C, Xiaoguang H, Jingying W, et al. Calvarial defect healing by recruitment of autogenous osteogenic stem cells using locally applied simvastatin. Biomaterials. 2013;34:9373–9380.
   PubMed Web of Science ®Google Scholar
• Kupcsik L, Meurya T, Flury M, et al. Statin‐induced calcification in human mesenchymal stem cells is cell death related. J Cell Mol Med. 2009;13:4465–4473.
   PubMed Web of Science ®Google Scholar
• Pagkalos J, Cha JM, Kang Y, et al. Simvastatin induces osteogenic differentiation of murine embryonic stem cells. J Bone Miner Res. 2010;25:2470–2478.
   PubMed Web of Science ®Google Scholar
• Jia Z, Zhang Y, Chen YH, et al. Simvastatin prodrug micelles target fracture and improve healing. J Control Rel. 2015;200:23–34.
   PubMed Web of Science ®Google Scholar
• Calixto JC, Lima CEV De C, Frederico L, et al. The influence of local administration of simvastatin in calvarial bone healing in rats. J Craniomaxillofac Surg. 2011;39:215–220.
   PubMed Web of Science ®Google Scholar
• Fukui T, Ii M, Shoji T, et al. Therapeutic effect of local administration of low-dose simvastatin-conjugated gelatin hydrogel for fracture healing. J Bone Miner Res. 2012;27:1118–1131.
   PubMed Web of Science ®Google Scholar
• Moriyama Y, Ayukawa Y, Ogino Y, et al. Local application of fluvastatin improves peri-implant bone quantity and mechanical properties: A rodent study. Acta Biomaterialia. 2010;6:1610–1618.
   PubMed Web of Science ®Google Scholar
• Pauly S, Back DA, Kaeppler K, et al. Influence of Statins locally applied from orthopedic implants on osseous integration. BMC Musculoskelet Disord. 2012;13:208.
   PubMed Web of Science ®Google Scholar
• Bleedorn JA, Sullivan R, Lu Y, et al. Percutaneous lovastatin accelerates bone healing but is associated with periosseous soft tissue inflammation in a canine tibial osteotomy model. J Orthop Res. 2014;32:210–216.
   PubMed Web of Science ®Google Scholar
• Ibrahim NI, Khamis MF, Yunoh MFM, et al. Targeted delivery of lovastatin and tocotrienol to fracture site promotes fracture healing in osteoporosis model: micro-computed tomography and biomechanical evaluation. PLoS ONE. 2014;9:e115595.
   PubMed Web of Science ®Google Scholar
• Zanette DL, Lorenzi JCC, Panepucci RA, et al. Simvastatin modulates mesenchymal stromal cell proliferation and gene expression. PLoS ONE. 2015;10:e0120137.
   PubMed Web of Science ®Google Scholar
• Issa JPM, Ingraci de Lucia C, Santos Kotake Dos BG, et al. The effect of simvastatin treatment on bone repair of femoral fracture in animal model. Growth Factors. 2015;33:139–148.
   PubMed Web of Science ®Google Scholar
• Tang L, Chen Y, Pei F, et al. Lithium chloride modulates adipogenesis and osteogenesis of human bone marrow-derived mesenchymal stem cells. Cell Physiol Biochem. 2015;37:143–152.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Yin J, Guan J, et al. Lithium stimulates human bone marrow derived mesenchymal stem cell proliferation through GSK‐3β‐dependent β‐catenin/Wnt pathway activation. FEBS Journal. 2014;281:5371–5389.
   PubMed Web of Science ®Google Scholar
• Satija NK, Sharma D, Afrin F, et al. High throughput transcriptome profiling of lithium stimulated human mesenchymal stem cells reveals priming towards osteoblastic lineage. PLoS ONE. 2013;8:e55769.
   PubMed Web of Science ®Google Scholar
• Bernick J, Wang Y, Sigal IA, et al. Parameters for lithium treatment are critical in its enhancement of fracture-healing in rodents. J Bone Joint Surg Am. 2014;96:1990–1998.
   PubMed Web of Science ®Google Scholar
• Garrett IR, Chen D, Gutierrez G, et al. Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro. J Clin Investig. 2003;111:1771–1782.
   PubMed Web of Science ®Google Scholar
• Ito Y, Fukushima H, Katagiri T, et al. Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active Smads. Biochem Biophys Res Commun. 2011;407:225–229.
   PubMed Web of Science ®Google Scholar
• Khedgikar V, Kushwaha P, Gautam J, et al. Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone. Cell Death Dis. 2013;4:e778.
   PubMed Web of Science ®Google Scholar
• Yoshii T, Nyman JS, Yuasa M, et al. Local application of a proteasome inhibitor enhances fracture healing in rats. J Orthop Res. 2015;33:1197–1204.
   PubMed Web of Science ®Google Scholar
• Carpentieri A, Díaz de Barboza G, Areco V, et al. New perspectives in melatonin uses. Pharmacological Res. 2012;65:437–444.
   PubMed Web of Science ®Google Scholar
• Son J-H, Cho Y-C, Sung I-Y, et al. Melatonin promotes osteoblast differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions through activation of PKD/p38 pathways. J Pineal Res. 2014;57:385–392.
   PubMed Web of Science ®Google Scholar
• Park K-H, Kang JW, Lee E-M, et al. Melatonin promotes osteoblastic differentiation through the BMP/ERK/Wnt signaling pathways. J Pineal Res. 2011;51:187–194.
   PubMed Web of Science ®Google Scholar
• Roth JA, Kim BG, Lin WL, et al. Melatonin promotes osteoblast differentiation and bone formation. J Biol Chem. 1999;274:22041–22047.
   PubMed Web of Science ®Google Scholar
• Nakade O, Koyama H, Ariji H, et al. Melatonin stimulates proliferation and type I collagen synthesis in human bone cells in vitro. J Pineal Res. 1999;27:106–110.
   PubMed Web of Science ®Google Scholar
• Sethi S, Radio NM, Kotlarczyk MP, et al. Determination of the minimal melatonin exposure required to induce osteoblast differentiation from human mesenchymal stem cells and these effects on downstream signaling pathways. J Pineal Res. 2010;49:222–238.
   PubMed Web of Science ®Google Scholar
• Calvo-Guirado JL, Ramírez-Fernández MP, Gómez-Moreno G, et al. Melatonin stimulates the growth of new bone around implants in the tibia of rabbits. J Pineal Res. 2010;49:356–363.
   PubMed Web of Science ®Google Scholar
• Calvo-Guirado JL, Gómez-Moreno G. Maté-Sánchez J-E et al. New bone formation in bone defects after melatonin and porcine bone grafts: experimental study in rabbits. Clin Oral Implants Res. 2015;26:399–406.
   PubMed Web of Science ®Google Scholar
• Ramírez-Fernández MP, Calvo-Guirado JL, de-Val JE-MS, et al. Melatonin promotes angiogenesis during repair of bone defects: a radiological and histomorphometric study in rabbit tibiae. Clin Oral Invest. 2013;17:147–158.
   PubMed Web of Science ®Google Scholar
• Erdem M. The effects of melatonin and caffeic acid phenethyl ester (CAPE) on fracture healing under ischemic conditions. Acta Orthop Traumatol Turc. 2014;48:339–345.
   PubMed Web of Science ®Google Scholar
• Aydin A, Memisoglu K, Cengiz A, et al. Effects of botulinum toxin A on fracture healing in rats: an experimental study. J Orthop Sci. 2012;17:796–801.
   PubMed Web of Science ®Google Scholar
• Wu C, Giaccia AJ, Rankin EB. Osteoblasts: a novel source of erythropoietin. Curr Osteoporos Rep. 2014;12:428–432.
   PubMed Web of Science ®Google Scholar
• Kim J, Jung Y, Sun H, et al. Erythropoietin mediated bone formation is regulated by mTOR signaling. J Cell Biochem. 2012;113:220–228.
   PubMed Web of Science ®Google Scholar
• Li C, Shi C, Kim J, et al. Erythropoietin promotes bone formation through EphrinB2/EphB4 signaling. J Dent Res. 2015;94:455–463.
   PubMed Web of Science ®Google Scholar
• Nair AM, Tsai Y-T, Shah KM, et al. The effect of erythropoietin on autologous stem cell-mediated bone regeneration. Biomaterials. 2013;34:7364–7371.
   PubMed Web of Science ®Google Scholar
• Holstein JH, Orth M, Scheuer C, et al. Erythropoietin stimulates bone formation, cell proliferation, and angiogenesis in a femoral segmental defect model in mice. Bone. 2011;49:1037–1045.
   PubMed Web of Science ®Google Scholar
• Garcia P, Speidel V, Scheuer C, et al. Low dose erythropoietin stimulates bone healing in mice. J Orthop Res. 2011;29:165–172.
   PubMed Web of Science ®Google Scholar
• Wan L, Zhang F, He Q, et al. EPO promotes bone repair through enhanced cartilaginous callus formation and angiogenesis. PLoS ONE. 2014;9:e102010.
   PubMed Web of Science ®Google Scholar
• Petrie Aronin CE, Shin SJ, Naden KB, et al. The enhancement of bone allograft incorporation by the local delivery of the sphingosine 1-phosphate receptor targeted drug FTY720. Biomaterials. 2010;31:6417–6424.
   PubMed Web of Science ®Google Scholar
• Petrie Aronin CE, Sefcik LS, Tholpady SS, et al. FTY720 promotes local microvascular network formation and regeneration of cranial bone defects. Tissue Eng Part A. 2010;16:1801–1809.
   PubMed Web of Science ®Google Scholar
• Behr B, Tang C, Germann G, et al. Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation. Stem Cells. 2011;29:286–296.
   PubMed Web of Science ®Google Scholar
• Gao C, Harvey EJ, Chua M, et al. MSC-seeded dense collagen scaffolds with a bolus dose of VEGF promote healing of large bone defects. Eur Cells Mater. 2013;26:195–207.
   PubMed Web of Science ®Google Scholar
• Yamada T, Kaneko H, Lizuka K, et al. Elevation of lymphocyte and hematopoietic stem cell numbers in mice transgenic for human granulocyte CSF. Lab Invest. 1996;74:384–394.
   PubMed Web of Science ®Google Scholar
• Kuethe F, Krack A, Fritzenwanger M, et al. Treatment with granulocyte-colony stimulating factor in patients with acute myocardial infarction. Evidence for a stimulation of neovascularization and improvement of myocardial perfusion. Pharmazie. 2006;61:957–961.
   PubMed Web of Science ®Google Scholar
• Du X, Xie Y, Xian CJ, et al. Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol. 2012;227:3731–3743.
   PubMed Web of Science ®Google Scholar
• Arias-Gallo J, Chamorro-Pons M, Avendaño C, et al. Influence of acidic fibroblast growth factor on bone regeneration in experimental cranial defects using spongostan and Bio-Oss as protein carriers. J Craniofac Surg. 2013;24:1507–1514.
   PubMed Web of Science ®Google Scholar
• Furuya H, Tabata Y, Kaneko K. Bone regeneration for murine femur fracture by gelatin hydrogels incorporating basic fibroblast growth factor with different release profiles. Tissue Eng Part A. 2014;20:1531–1541.
   PubMed Web of Science ®Google Scholar
• Marzban L, McNeill JH. Insulin‐like actions of vanadium: potential as a therapeutic agent. J Trace Elem Exp Med. 2003;16:253–267.
   Google Scholar
• Schmidmaier G, Wildemann B, Gäbelein T, et al. Synergistic effect of IGF-I and TGF-beta1 on fracture healing in rats: single versus combined application of IGF-I and TGF-beta1. Acta Orthop Scand. 2003;74:604–610.
   PubMed Web of Science ®Google Scholar
• Paglia DN, Wey A, Park AG, et al. The effects of local vanadium treatment on angiogenesis and chondrogenesis during fracture healing. J Orthop Res. 2012;30:1971–1978.
   PubMed Web of Science ®Google Scholar
• Paglia DN, Wey A, Hreha J, et al. Local vanadium release from a calcium sulfate carrier accelerates fracture healing. J Orthop Res. 2014;32:727–734.
   PubMed Web of Science ®Google Scholar